Professional Drug Information - GAF149
Title: Odborné informace o léčivech
Guaranteed by: Department of Social and Clinical Pharmacy (16-16220)
Faculty: Faculty of Pharmacy in Hradec Králové
Actual: from 2016
Semester: summer
Points: 0
E-Credits: 1
Examination process: summer s.:
Hours per week, examination: summer s.:0/1, C [HT]
Capacity: unknown / unknown (unknown)
Min. number of students: unlimited
4EU+: no
Virtual mobility / capacity: no
Key competences:  
State of the course: not taught
Language: English
Teaching methods: full-time
Level:  
Explanation: (F,3.r.)
Note: course can be enrolled in outside the study plan
enabled for web enrollment
Guarantor: PharmDr. Kateřina Malá, Ph.D.
PharmDr. Petra Rozsívalová
PharmDr. Eva Zimčíková, Ph.D.
Classification: Pharmacy > Special Core Subjects
Co-requisite : GAF155
Is co-requisite for: GAF335, GAF291, GAF282, GAF202
Examination dates   Schedule   
Annotation -
students are familiarized with various information on drugs and trained where to find reliable, up-to-date information and to assess the quality and validity of the material so as to provide relevant information to patients about their medication (either on prescription or non-prescription drugs).
Last update: OLIVOVA/FAF.CUNI.CZ (24.06.2008)
Literature -

1. Greenhalgh T.:How to Read a Paper: The Basics of Evidence-Based Medicine. Blackwell Publishing Ltd. 2006. 3rd edition.

2. University of Oxford: http://www.jr2.ox.ac.uk/bandolier/index.html

3. Healthy Skepticism: http://www.healthyscepticism.org/

Last update: OLIVOVA/FAF.CUNI.CZ (24.06.2008)
Teaching methods -

Teaching Method: seminars.

Credit is given for active participation + essay (evaluated as pass/fail).

Last update: OLIVOVA/FAF.CUNI.CZ (24.06.2008)
Syllabus -

evidence based medicine principles; classification of information sources; clinical trials designs (primary sources: randomized controlled clinical trial, cohort trial, case-control trial, cases, case-series; secondary sources: systematic reviews and meta-analysis); measures of effect size (odds ratio- OR; relative risk ? RR; relative risk increase RRI, relative risk reduction ? RRR; absolute risk AR; absolute risk increase ARI, absolute risk reduction ? ARR; number needed to treat/to harm- NNT/NNH; confidence interval; interpretation of the study results); databases (bibliographic ? MEDLINE/PubMED; EMBASE; full-text- EBSCO, PROQUEST 5000; factographic ? Micromedex Health Care Series), quality of the information on the internet; drug promotion; drug information centres, electronic discussion groups on medicines; ethical issues in the handling of information.

Last update: OLIVOVA/FAF.CUNI.CZ (24.06.2008)